SEC Form 4/A · accession 0001209191-17-046966
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Joseph M Feczko
Director
Period of report
May 25, 2017
Accepted (ET)
Aug 1, 2017 · 6:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 25, 2017 | A | 12,912 | $0.00 | A | 82,096 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F1 | — | May 25, 2017 | D | 12,912 | D | — | — | Common Stock | 12,912 | 0 | D |
Explanation of responses
- F1The reporting person is amending the Form 4 originally filed to report restricted stock units awarded on May 25, 2017. The Form 4 should have reported the award as a restricted stock award. The restricted stock awarded on May 25, 2017, vests 100% on May 25, 2018, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.
- F2Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.